Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia
The purpose of this study is to assess the impact of an individual physical activity intervention (IPAI) on health-related quality of life (HRQoL) in participants with first line or relapsed chronic lymphocytic leukemia (CLL) initiating ibrutinib in a routine clinical practice setting. HRQoL will be measured using functional assessment of cancer therapy - general scale (FACT-G).
- EligibilityCriteria: Inclusion Criteria:  Participants newly treated with ibrutinib for first line or relapsed CLL (treatment is being initiated or has been initiated within the last 8 days as a maximum) Participants agreed to follow the individual physical activity intervention (IPAI) Participants using or having access to a compatible and appropriate electronic device such as smartphone, laptop or tablet Participants with Internet access at home and email address Participants agreed to wear a connected watch 24 hours a day for all the duration of the study  Exclusion Criteria:  Pregnant participants or planning to become pregnant while enrolled in this study Participants with inability or deemed unsafe to practice physical activity Participants who have received an investigational drug (including investigational vaccines) or used an invasive investigational medical device within 90 days before the inclusion visit Participants who are currently involved in an interventional study Participants with probable difficulties in using the digital tool autonomously - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult - StudyPopulation: The study population will include participants aged at least 18 years of age with chronic lymphocytic leukemia (CLL). - SamplingMethod: Probability Sample